TGFB1 and neoplasm: Emerging data and thought suggest that the efficacy of TGFβ antagonist therapy in cancer might not only derive from direct intrinsic effects on tumor cells, but also involves tumor extrinsic mechanisms acting in the tumor micro-environment.